1. The environmental monitoring program in a GMP environment;Sutton S.V.W.;J. GXP Compliance,2010
2. Economic Cost of a Listeria monocytogenes Outbreak in Canada, 2008
3. Food and Drug Administration (FDA)2004.Sterile Drug Products Produced by Aseptic Processing – Current Good Manufacturing Practice. Guidance for Industry. US Department of Health and Human Services.
4. Food and Drug Administration (FDA)2011.FDA Regulation 21 CFR Part 211 –Current Good Manufacturing Practice for Finished Pharmaceuticals. US FDA.